TrialStem cell research & therapy2026

An open phase I/IIa study evaluating safety, patient-reported outcomes and voice function after surgery, local administration of mesenchymal stromal cells and voice training in patients with vocal fold scarring and dysphonia.

Erika Bergström Börlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.